CRD-B 📈 Crawford & - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2246331076

CRD-B: Claims Management, Insurance Services, Risk Management, Outsourcing Solutions

Crawford & Company provides claims management and outsourcing solutions for carriers, brokers, and corporations in the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America. The North America Loss Adjusting segment provides claims management services to insurance carriers and self-insured entities risk, including property, public liability, automobile liability, and marine insurances. The International Operations segment provides claims management and adjusting services to insurance carriers and self-insured entities; and field investigation and the evaluation and resolution of property and casualty insurance claims. The Broadspire segment offers claims management services, including workers' compensation, liability, property, accident and health, and disability claims management; accident and health claims programs; disability and leave management services, as well as legal services, risk management information, and consultative analytical services. This segment also provides medical management services; administration services; physician review services, as well as claims and risk management services and technology solutions; desktop claim adjusting and evaluation of claims; initial loss reporting services for claimants; and loss mitigation services, such as medical bill review, medical case management and vocational rehabilitation services. The Platform Solutions segment offers managed repair service and outsourced contractor management to national and regional personal and commercial insurance carriers; services to insurance companies on losses caused by all types of natural disasters, such as fires, hailstorms, hurricanes, earthquakes, floods, as well as man-made disasters, such as oil spills, chemical releases, and explosions; and outsourced subrogation claims management, recovery, and consultative services for the property and casualty insurance industry. The company was founded in 1941 and is headquartered in Atlanta, Georgia. Web URL: https://www.crawco.com

Additional Sources for CRD-B Stock

CRD-B Stock Overview

Market Cap in USD 559m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Life & Health Insurance
IPO / Inception 1990-01-12

CRD-B Stock Ratings

Growth 5y 26.2%
Fundamental 25.0%
Dividend 57.1%
Rel. Strength Industry -98.2
Analysts 5/5
Fair Price Momentum 10.61 USD
Fair Price DCF 11.43 USD

CRD-B Dividends

Dividend Yield 12m 2.54%
Yield on Cost 5y 3.27%
Annual Growth 5y 5.39%
Payout Consistency 81.4%

CRD-B Growth Ratios

Growth Correlation 3m -29.5%
Growth Correlation 12m -0.5%
Growth Correlation 5y 54.3%
CAGR 5y 5.15%
CAGR/Mean DD 5y 0.22
Sharpe Ratio 12m 0.06
Alpha -25.19
Beta 0.75
Volatility 36.59%
Current Volume 47.8k
Average Volume 20d 11.8k
What is the price of CRD-B stocks?
As of December 21, 2024, the stock is trading at USD 11.01 with a total of 47,800 shares traded.
Over the past week, the price has changed by -0.09%, over one month by +2.23%, over three months by -3.08% and over the past year by +0.60%.
Is Crawford & a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Crawford & is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.02 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRD-B as of December 2024 is 10.61. This means that CRD-B is currently overvalued and has a potential downside of -3.63%.
Is CRD-B a buy, sell or hold?
Crawford & has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy CRD-B.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CRD-B stock price target?
According to ValueRays Forecast Model, CRD-B Crawford & will be worth about 11.5 in December 2025. The stock is currently trading at 11.01. This means that the stock has a potential upside of +4.36%.
Issuer Forecast Upside
Wallstreet Target Price 13 18.1%
Analysts Target Price 12.5 13.5%
ValueRay Target Price 11.5 4.4%